Patent application number | Description | Published |
20090048444 | Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives - The present invention is directed to a novel method of preparing of 2,4,8-trisubstituted pyrido[2,3-d]pyrimidin-7-one pharmacophores of Formula (II) or (IIa) | 02-19-2009 |
20090069318 | Novel Compounds - Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors. | 03-12-2009 |
20090156597 | Novel Compounds - Novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors. | 06-18-2009 |
20090239846 | Novel Compounds - Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors. | 09-24-2009 |
20090275604 | M3 Muscarinic Acetylcholine Receptor Antagonists - Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. | 11-05-2009 |
20100093765 | NOVEL COMPOUNDS - Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors. | 04-15-2010 |
20100093766 | NOVEL COMPOUNDS - Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors. | 04-15-2010 |
Patent application number | Description | Published |
20090197871 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics - The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis. | 08-06-2009 |
20090203657 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics - The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, | 08-13-2009 |
20090203677 | Dual Pharmacophores - PDE4-Muscarinic Antagonistics - The present invention relates to novel compounds of Formula (I) | 08-13-2009 |
20120142717 | COMPOUNDS - The present invention relates to novel compounds that inhibit Lp-PLA | 06-07-2012 |
20130030012 | COMPOUNDS - The present invention relates to novel compounds that inhibit Lp-PLA | 01-31-2013 |
20130178488 | TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES - The present invention relates to novel compounds that inhibit Lp-PLA | 07-11-2013 |
20130252963 | PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASE OR CONDITIONS MEDIATED BY LP-PLA2 - The present invention relates to novel compounds that inhibit Lp-PLA | 09-26-2013 |
20130252986 | COMPOUNDS - The present invention relates to novel compounds that inhibit Lp-PLA | 09-26-2013 |
20140113922 | COMPOUNDS - The present invention relates to novel compounds that inhibit Lp-PLA | 04-24-2014 |
20140179715 | 2,3-DIHYDROIMIDAZO[1 ,2-c] PYRIMIDIN-5(1 H)-ONE COMPOUNDS USE AS LP-PLA2 INHIBITORS - Disclosed are 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1H)-one compounds that inhibit Lp-PLA | 06-26-2014 |
20140179716 | BICYCLIC PYRIMIDONE COMPOUNDS - The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA | 06-26-2014 |
20140213599 | COMPOUNDS - The present invention relates to novel compounds that inhibit Lp-PLA | 07-31-2014 |
20140378487 | TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES - The present invention relates to novel compounds that inhibit Lp-PLA | 12-25-2014 |
20150099756 | PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP-PLA2 - The present invention relates to novel compounds that inhibit Lp-PLA | 04-09-2015 |